Japanese encephalitis vaccine (live, attenuated)
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Summary
Japanese encephalitis vaccine (live, attenuated) is a live attenuated vaccine against Japanese encephalitis.
- Generic Name
- Japanese encephalitis vaccine (live, attenuated)
- DrugBank Accession Number
- DB16577
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Japanese encephalitis live attenuated strain sa 14-14-2 antigen
- Japanese encephalitis live attenuated strain sa 14-14-2 vaccine
- Japense encephalitis vaccine, live, attenuated
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prophylaxis of Japanese encephalitis virus disease •••••••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- International/Other Brands
- CD.JEVAX / IMOJEV / THAIJEV
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ZZ1CP75F3U
- CAS number
- Not Available
References
- General References
- FDA Thailand: Japanese Encephalitis Vaccine (Live, Attenuated) Injection [Link]
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Diagnostic Japanese Encephalitis 1 somestatus stop reason just information to hide 4 Completed Prevention Encephalitis 1 somestatus stop reason just information to hide 4 Completed Prevention Japanese Encephalitis 2 somestatus stop reason just information to hide 4 Completed Prevention Japanese Encephalitis / Measles / Mumps / Rubella 1 somestatus stop reason just information to hide 4 Unknown Status Prevention Japanese Encephalitis 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, powder, lyophilized, for suspension Subcutaneous 4.9 log PFU/dose Solution 4.9 logPFU Injection 4.9 logPFU Injection, powder, for suspension 4.9 logPFU - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at February 09, 2021 17:14 / Updated at May 05, 2021 20:32